Results 51 to 60 of about 1,044,908 (274)

Human Stem Cells for Ophthalmology: Recent Advances in Diagnostic Image Analysis and Computational Modelling [PDF]

open access: yes, 2023
\ua9 2023, The Author(s).Purpose of Review: To explore the advances and future research directions in image analysis and computational modelling of human stem cells (hSCs) for ophthalmological applications.
Figueiredo FC   +5 more
core  

Clinical translation of patient-derived tumour organoids- bottlenecks and strategies

open access: yesBiomarker Research, 2022
Multiple three-dimensional (3D) tumour organoid models assisted by multi-omics and Artificial Intelligence (AI) have contributed greatly to preclinical drug development and precision medicine.
Malia Alexandra Foo   +9 more
doaj   +1 more source

Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer [PDF]

open access: yes, 2017
OBJECTIVE: Colorectal cancer (CRC) leads to significant morbidity/mortality worldwide. Defining critical research gaps (RG), their prioritisation and resolution, could improve patient outcomes.DESIGN: RG analysis was conducted by a multidisciplinary ...
  +22 more
core   +12 more sources

A hybrid physics-based and data-driven framework for cellular biological systems: Application to the morphogenesis of organoids [PDF]

open access: yes, 2023
How cells orchestrate their cellular functions remains a crucial question to unravel how they organize in different patterns. We present a framework based on artificial intelligence to advance the understanding of how cell functions are coordinated ...
Camacho-Gomez, Daniel   +4 more
core   +1 more source

Augmenting adaptive immunity: progress and challenges in the quantitative engineering and analysis of adaptive immune receptor repertoires

open access: yes, 2019
The adaptive immune system is a natural diagnostic and therapeutic. It recognizes threats earlier than clinical symptoms manifest and neutralizes antigen with exquisite specificity.
Abbas   +478 more
core   +1 more source

Pharmaco-Proteogenomic Characterization of Liver Cancer Organoids for Precision Oncology [PDF]

open access: yes, 2023
Organoid models have the potential to recapitulate the biological and pharmacotypic features of parental tumors. Nevertheless, integrative pharmaco-proteogenomics analysis for drug response features and biomarker investigation for precision therapy of ...
Cai, Shangli   +33 more
core   +2 more sources

Open and remotely accessible Neuroplatform for research in wetware computing

open access: yesFrontiers in Artificial Intelligence
Wetware computing and organoid intelligence is an emerging research field at the intersection of electrophysiology and artificial intelligence. The core concept involves using living neurons to perform computations, similar to how Artificial Neural ...
Fred D. Jordan   +4 more
doaj   +1 more source

Combining Automated Organoid Workflows with Artificial Intelligence‐Based Analyses: Opportunities to Build a New Generation of Interdisciplinary High‐Throughput Screens for Parkinson's Disease and Beyond

open access: yesMovement Disorders, 2021
Parkinson's disease (PD) is the second most common neurodegenerative disease and primarily characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta of the midbrain. Despite decades of research and the development of various
Henrik Renner, H. Schöler, J. Bruder
semanticscholar   +1 more source

Morpho-Rheological Fingerprinting of Rod Photoreceptors Using Real-Time Deformability Cytometry

open access: yes, 2019
Distinct cell-types within the retina are mainly specified by morphological and molecular parameters, however, physical properties are increasingly recognized as a valuable tool to characterize and distinguish cells in diverse tissues.
Ader, M.   +7 more
core   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

open access: yesMolecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy